Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Oxidation Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102603716A details a novel titanium-catalyzed asymmetric oxidation for (S)-pantoprazole. Achieve 100% ee value with streamlined processing for reliable pharmaceutical intermediate supply.
Patent CN106045804B enables aqueous asymmetric oxidation. Reduces solvent waste and improves catalyst recovery for pharmaceutical intermediates.
Patent CN103788069B reveals advanced asymmetric oxidation for esomeprazole magnesium trihydrate. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.